Company profile
Ticker
RHHVF
Exchange
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
510304944
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
22 Apr 21
SC TO-T/A
Third party tender offer statement (amended)
13 Apr 21
SC TO-T/A
Third party tender offer statement (amended)
6 Apr 21
SC TO-T
Third party tender offer statement
25 Mar 21
SC TO-C
Information about tender offer
18 Mar 21
SC TO-C
Information about tender offer
17 Mar 21
SC TO-C
Information about tender offer
15 Mar 21
SC TO-C
Information about tender offer
15 Mar 21
SC TO-T/A
Third party tender offer statement (amended)
17 Dec 19
SC TO-T/A
Third party tender offer statement (amended)
16 Dec 19
Latest ownership filings
News
Roche's Genentech Granted Priority Review By FDA For Inavolisib, An Investigational Oral Therapy, In Combination With Palbociclib (Ibrance) And Fulvestrant
29 May 24
Reported Earlier, Roche And Hitachi High-Tech Extend 46-Year Partnership For Diagnostic Testing Advances
28 May 24
Roche Announces That The FDA Granted Breakthrough Therapy Designation To Genentech's Inavolisib For Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation
21 May 24
Roche's Genentech Reports Phase Ib Results For Its Dual GLP-1/GIP Receptor Agonist CT-388 In People With Obesity
16 May 24